Keywords: Cell-mediated gene therapy; Adenoviral vector; Spinal cord injury; Mini pigs; Human umbilical cord blood mononuclear cell; Vascular endothelial growth factor (VEGF); Glial cell-derived neurotrophic factor (GDNF); Neural cell adhesion molecule (NCAM);